Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer
Pik‐Fang Kho,Frederic Amant,Daniela Annibali,Katie Ashton,John Attia,Paul L. Auer,Matthias W. Beckmann,Amanda Black,Louise Brinton,Daniel D. Buchanan,Stephen J. Chanock,Chu Chen,Maxine M. Chen,Timothy H. T. Cheng,Linda S. Cook,Marta Crous‐Bous,Kamila Czene,Immaculata De Vivo,Joe Dennis,Thilo Dörk,Sean C. Dowdy,Alison M. Dunning,Matthias Dürst,Douglas F. Easton,Arif B. Ekici,Peter A. Fasching,Brooke L. Fridley,Christine M. Friedenreich,Montserrat García‐Closas,Mia M. Gaudet,Graham G. Giles,Ellen L. Goode,Maggie Gorman,Christopher A. Haiman,Per Hall,Susan E. Hankinson,Alexander Hein,Peter Hillemanns,Shirley Hodgson,Erling A. Hoivik,Elizabeth G. Holliday,David J. Hunter,Angela Jones,Peter Kraft,Camilla Krakstad,Diether Lambrechts,Loic Le Marchand,Xiaolin Liang,Annika Lindblom,Jolanta Lissowska,Jirong Long,Lingeng Lu,Anthony M. Magliocco,Lynn Martin,Mark McEvoy,Roger L. Milne,Miriam Mints,Rami Nassir,Geoffrey Otton,Claire Palles,Loreall Pooler,Tony Proietto,Timothy R. Rebbeck,Stefan P. Renner,Harvey A. Risch,Matthias Rübner,Ingo Runnebaum,Carlotta Sacerdote,Gloria E. Sarto,Fredrick Schumacher,Rodney J. Scott,V. Wendy Setiawan,Mitul Shah,Xin Sheng,Xiao‐Ou Shu,Melissa C. Southey,Emma Tham,Ian Tomlinson,Jone Trovik,Constance Turman,Jonathan P. Tyrer,David Van Den Berg,Zhaoming Wang,Nicolas Wentzensen,Lucy Xia,Yong‐Bing Xiang,Hannah P. Yang,Herbert Yu,Wei Zheng,Penelope M. Webb,Deborah J. Thompson,Amanda B. Spurdle,Dylan M. Glubb,Tracy A. O'Mara
DOI: https://doi.org/10.1002/ijc.33206
2020-08-07
International Journal of Cancer
Abstract:Blood lipids have been associated with the development of a range of cancers, including breast, lung and colorectal cancer. For endometrial cancer, observational studies have reported inconsistent associations between blood lipids and cancer risk. To reduce biases from unmeasured confounding, we performed a bidirectional, two‐sample Mendelian randomization analysis to investigate the relationship between levels of three blood lipids (low‐density lipoprotein (LDL) and high‐density lipoprotein (HDL) cholesterol, and triglycerides) and endometrial cancer risk. Genetic variants associated with each of these blood lipid levels (P < 5×10‐8) were identified as instrumental variables, and assessed using genome‐wide association study data from the Endometrial Cancer Association Consortium (12,906 cases and 108,979 controls) and the Global Lipids Genetic Consortium (n=188,578). Mendelian randomization analyses found genetically raised LDL cholesterol levels to be associated with lower risks of endometrial cancer of all histologies combined, and of endometrioid and non‐endometrioid subtypes. Conversely, higher genetically predicted HDL cholesterol levels were associated with increased risk of non‐endometrioid endometrial cancer. After accounting for the potential confounding role of obesity (as measured by genetic variants associated with body mass index), the association between genetically predicted increased LDL cholesterol levels and lower endometrial cancer risk remained significant, especially for non‐endometrioid endometrial cancer. There was no evidence to support a role for triglycerides in endometrial cancer development. Our study supports a role for LDL and HDL cholesterol in the development of non‐endometrioid endometrial cancer. Further studies are required to understand the mechanisms underlying these findings.
oncology